NFL signs Novartis as first pharmaceutical partner-source
Novartis beats Q4 earnings consensus as drug sales surge
CKW launches new data center in Rotkreuz, Switzerland
Media Library
Sustainable Buildings
Novartis wins temporary pause to Entresto generic launch in US
Suurstoffi
US appeals court reinstates pause on generic version of Novartis' Entresto
Delivering value through digital manufacturing
Novartis must face claims it paid kickbacks to promote MS drug, US appeals court rules
Novartis says 330 jobs hit as it closes MorphoSys sites
Novartis buys Blackstone's Anthos for up to $3.1 billion
Novartis raises sales guidance until 2028
Novartis in up to $2.9 billion licensing deal for PTC Therapeutics Huntington's disease drug
Novartis CEO 'very confident' on sales target, doesn't fear patent cliff - newspaper
Eye drug success mitigates Roche's earnings decline
Roche expects higher 2021 sales as Delta spurs COVID-19 tests
New cancer immunotherapy fails in first Roche trial
Roche inadvertently publishes positive interim trial data on lung cancer drug
Roche buys back shares as family group reduces voting stake in drugmaker
Novartis misses Q4 profit expectations as costs disappoint
Roche warns multiple sclerosis drug development hit by Ukraine war
Michael Glinski is the new Managing Director in Switzerland
Roche's head of pharmaceuticals to leave company
India approves Roche/Regeneron antibody cocktail to treat COVID-19
U.S. FDA approves Roche's lymphoma therapy
We are diverse, We are Global Operations, We are Roche
Introduction of sacubitril/valsartan in primary care follow-up of heart failure: a prospective observational study (THESEUS)
WHO calls on Roche to ensure fair access to COVID-19 drug amid shortage
Office market Zug
Ancient mammoth remains found in Switzerland
Genentech withdraws use of Gavreto in US for a type of thyroid cancer, says partner Blueprint
US court upholds Roche win in patent case over blockbuster hemophilia drug
Infinigate Group appoints Marcus Meloni as new CEO Europe
Tour de Suisse 2015
Roche acquires DNA sequencing firm for up to $350 million
Roche to buy US cancer drug group Seragon
Sefar Architecture - Experiences, ideas and new ways with architecture fabrics
Roche to bid $10bn for full control of Japan’s Chugai
First wooden high-rise to be built in Switzerland
New expert forum - Smart Digital Business for Swiss SMEs
Swiss air quality improves in 2020 but depends on location
AVENTURA begeisterten in Luzern und Fribourg
Can Roche Challenge Lilly and Novo in the Weight Loss Market?